Major depressive disorder, social anxiety disorder

Main|Search|PHGKB

From Tier Table Database

CDC Office of Public Health Genomics (OPHG) conducts horizon scanning (a systematic research method to find and follow novel technologies appearing in the literature) to identify and track the progress of genomic tests as they move from research into clinical and public health practice. As an aid in organizing horizon scanning results, OPHG ranks genomic tests, and family health history applications, by levels of evidence. See detail.

---

Disease/Disorder	Test to be Assessed	Intended Use	Tier Classified	Detail
Non-psychotic depression	CYP450 testing	Pharmacogenomic, and pharmacogenomics dose, for SSRIs	Tier 3
Major depressive disorder, social anxiety disorder	CYP2D6	Pharmacogenomic, and pharmacogenomics - dose, for venlafaxine	Tier 2

more